Scarica l'app Stockscreener
15.83
12.35%
1.74
Pre-mercato:
16.04
0.21
+1.33%
Precedente Chiudi:
$14.09
Aprire:
$14.3
Volume 24 ore:
1.99M
Relative Volume:
1.18
Capitalizzazione di mercato:
$745.43M
Reddito:
$217.11M
Utile/perdita netta:
$-651.19M
Rapporto P/E:
-1.2186
EPS:
-12.99
Flusso di cassa netto:
$-387.26M
1 W Prestazione:
-1.62%
1M Prestazione:
+54.14%
6M Prestazione:
+91.88%
1 anno Prestazione:
+103.21%
Intervallo 1D:
$14.26
$16.09
Intervallo di 1 settimana:
$12.44
$16.21
Portata 52W:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Nome
Ginkgo Bioworks Holdings Inc
Settore
Industria
Telefono
(877) 442-5362
Indirizzo
27 DRYDOCK AVENUE, BOSTON
Confronta DNA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
15.83 | 834.12M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.90 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
470.27 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.42 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
815.61 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
316.15 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-15 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-05-10 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-02 | Downgrade | Goldman | Neutral → Sell |
| 2023-05-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Iniziato | Berenberg | Buy |
| 2022-10-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2022-02-23 | Iniziato | Goldman | Neutral |
| 2022-02-01 | Iniziato | BofA Securities | Neutral |
| 2022-01-28 | Iniziato | BofA Securities | Buy |
| 2022-01-07 | Iniziato | BTIG Research | Buy |
| 2021-11-29 | Iniziato | Jefferies | Buy |
| 2021-10-13 | Iniziato | Raymond James | Outperform |
| 2021-10-12 | Iniziato | William Blair | Outperform |
| 2021-09-20 | Iniziato | HSBC Securities | Buy |
Mostra tutto
Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie
Advanced analytics toolkit walkthrough for Ginkgo Bioworks Holdings Inc.Quarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com
Is Ginkgo Bioworks Holdings Inc. stock oversold or undervaluedWeekly Gains Summary & Technical Buy Zone Confirmations - newser.com
Is Ginkgo Bioworks Holdings Inc. still worth holding after the dipTrade Volume Summary & High Accuracy Investment Signals - newser.com
Visual trend scoring systems applied to Ginkgo Bioworks Holdings Inc.2025 Support & Resistance & Real-Time Stock Movement Alerts - newser.com
Ginkgo Bioworks Holdings, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Custom watchlist performance reports with Ginkgo Bioworks Holdings Inc.Insider Selling & Weekly Return Optimization Plans - newser.com
How Ginkgo Bioworks Holdings Inc. Class stock behaves in tightening cyclesExit Point & Reliable Price Breakout Alerts - newser.com
How sentiment analysis helps forecast Ginkgo Bioworks Holdings Inc.2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com
Ginkgo Bioworks Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Has Ginkgo Bioworks Holdings Inc. found a price floorGlobal Markets & Consistent Profit Trading Strategies - newser.com
Ginkgo Bioworks (NYSE:DNA) Sets New 12-Month HighTime to Buy? - MarketBeat
Will Ginkgo Bioworks Holdings Inc. Class stock benefit from sector leadershipJuly 2025 EndofMonth & Reliable Price Action Trade Plans - newser.com
Can Ginkgo Bioworks Holdings Inc. stock outperform in 2025 bull market2025 Growth vs Value & Free Community Supported Trade Ideas - newser.com
Looking at the Narrative for Ginkgo Bioworks After Recent Analyst and Strategy Updates - Yahoo Finance
Weiss Ratings Reaffirms Sell (D-) Rating for Ginkgo Bioworks (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (DNA) Registers a Bigger Fall Than the Market: Important Facts to Note - sharewise.com
Using AI based signals to follow Ginkgo Bioworks Holdings Inc.Portfolio Growth Summary & Long-Term Investment Growth Plans - newser.com
Ginkgo Bioworks Holdings Inc. stock chart pattern explained2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Can Ginkgo Bioworks Holdings Inc. Class stock resist broad market declinesJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
Ginkgo Bioworks (NYSE:DNA) Trading 14.8% HigherStill a Buy? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Down 4.1% Following Insider Selling - MarketBeat
Why Ginkgo Bioworks Holdings Inc. stock could benefit from AI revolutionJuly 2025 Update & Real-Time Chart Pattern Alerts - newser.com
Do Lower Revenue Projections Reveal a Strategic Pivot for Ginkgo Bioworks (DNA)? - Sahm
Will Ginkgo Bioworks Holdings Inc. stock reach Wall Street targetsJuly 2025 Action & Daily Profit Focused Stock Screening - newser.com
Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know - MSN
Ginkgo Bioworks (NYSE:DNA) Insider Sells $84,135.00 in Stock - MarketBeat
How to monitor Ginkgo Bioworks Holdings Inc. with trend dashboardsMarket Activity Report & Reliable Volume Spike Alerts - newser.com
Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Shares Climb 45% But Its Business Is Yet to Catch Up - simplywall.st
Risk vs reward if holding onto Ginkgo Bioworks Holdings Inc.2025 Retail Activity & Stepwise Trade Execution Plans - newser.com
Ginkgo Bioworks Holdings Inc Azioni (DNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.09%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):